Similar articles

• Totect: a new agent for treating anthracycline extravasation.

  Schulmeister L. Schulmeister L. Clin J Oncol Nurs. 2007 Jun;11(3):387-95. doi: 10.1188/07.CJON.387-395. Clin J Oncol Nurs. 2007. PMID: 17623623 Review.
• TopoTarget responds.

  Parsons JL Jr. Parsons JL Jr. Clin J Oncol Nurs. 2007 Dec;11(6):789. doi: 10.1188/07.CJON.789. Clin J Oncol Nurs. 2007. PMID: 18063535 No abstract available.
• Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.

  Kane RC, McGuinn WD Jr, Dagher R, Justice R, Pazdur R. Kane RC, et al. Oncologist. 2008 Apr;13(4):445-50. doi: 10.1634/theoncologist.2007-0247. Oncologist. 2008. PMID: 18448560
• Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.

  Tyson AM, Gay WE. Tyson AM, et al. Ann Pharmacother. 2010 May;44(5):922-5. doi: 10.1345/aph.1M636. Epub 2010 Apr 6. Ann Pharmacother. 2010. PMID: 20371757
• Dexrazoxane for anthracycline extravasation.

  Langer SW. Langer SW. Expert Rev Anticancer Ther. 2007 Aug;7(8):1081-8. doi: 10.1586/14737140.7.8.1081. Expert Rev Anticancer Ther. 2007. PMID: 18028016 Review.